MedTrace Logo

Bromelain and Escin in the Reduction of Postoperative Sequelae in Periodontal and Implant Surgery

NCT04657874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-09-13

No results posted yet for this study

Summary

A randomized clinical trial will be performed in parallel, placebo controlled, triple-blind to evaluate the effectiveness of the association Bromelina and Horse-chestnut (titrated in escin) (Noflogo®, Mavenpharma s.r.l., Rome, Italy) in the management of post trauma-surgery following surgery periodontal and implant surgery.

Conditions

  • Postoperative Pain
  • Edema
  • Swelling Lips & Face

Interventions

OTHER

Bromelains and Escin Oral Tablet

Supportive care after oral surgery

OTHER

Placebo

Oral tablet without the active principle

Sponsors & Collaborators

  • Dr. Leonardo Mancini

    collaborator UNKNOWN

  • Tommaso Pizzolante

    collaborator UNKNOWN

  • University of L'Aquila

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-05-15
Completion
2021-05-27

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04657874 on ClinicalTrials.gov